HomeInsights52 Week High Stocks

Bafna Pharmaceuticals Ltd 52 Week High

Bafna Pharmaceuticals Ltd 52 Week High

stocks purchased

₹ 0.0 Cr

Volume Transacted

(Jan 7, 2025)

stocks purchased

1.5 K

Stocks Traded

(Jan 7, 2025)

Last Updated on: Jan 07, 2025

Image

Bafna Pharmaceuticals Ltd

NSE: BAFNAPH

YEARHIGH

₹ 112.2

Last updated on: Jan 06, 2025

Key Highlights

  • The 52 Week HIGH of Bafna Pharmaceuticals Ltd is ₹ 112.2 as of 06 Jan 25 .

Company Fundamentals for Bafna Pharmaceuticals Ltd

No data available

Market Price of Bafna Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Bafna Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
06 Jan 202579.61
03 Jan 202582
02 Jan 202583.95
01 Jan 202580.32
31 Dec 202476.5
30 Dec 202478.23
27 Dec 202480.99
23 Dec 202482
20 Dec 202481
19 Dec 202481.29

Asset Value vs Market Value of Bafna Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Bafna Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Bafna Pharmaceuticals Ltd

No data available

* All values are in crore

Bafna Pharmaceuticals Ltd News Hub

News

Bafna Pharmaceuticals to discuss results

Bafna Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 11 N...

Read more

04 Nov 2024 18:39

News

Bafna Pharmaceuticals schedules AGM

Bafna Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will ...

Read more

05 Sep 2024 10:29

News

Bafna Pharmaceuticals to convene AGM

Bafna Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will ...

Read more

04 Sep 2024 17:49

News

Bafna Pharmaceuticals to declare Quarterly Result

Bafna Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 A...

Read more

10 Aug 2024 13:56

News

Bafna Pharmaceuticals to hold board meeting

Bafna Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 29 M...

Read more

28 May 2024 13:49

News

Bafna Pharmaceuticals to declare Quarterly Result

Bafna Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 12 F...

Read more

03 Feb 2024 14:11

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week High of Bafna Pharmaceuticals Ltd

What is the significance of Bafna Pharmaceuticals Ltd reaching its 52-week high?

Bafna Pharmaceuticals Ltd reaching its 52-week high indicates strong market confidence and a positive outlook on the company's financial health and growth prospects. This milestone often reflects successful business performance and can boost investor sentiment.

Why do investors monitor Bafna Pharmaceuticals Ltd 52-week high?

Investors monitor Bafna Pharmaceuticals Ltd 52-week high to gauge the stock's peak performance and overall market strength, which can indicate robust financial health and growth potential. It also helps them assess if the stock is trading near its maximum value, influencing decisions on buying, holding, or selling.

Is Bafna Pharmaceuticals Ltd a good buy when it hits its 52-week high?

Whether Bafna Pharmaceuticals Ltd is a good buy at its 52-week high depends on various factors, including the company's future growth prospects, overall market conditions, individual investment strategies, and other important Bafna Pharmaceuticals Ltd fundamentals.

What should I consider before investing in Bafna Pharmaceuticals Ltd at its 52-week high?

Before investing in Bafna Pharmaceuticals Ltd at its 52-week high, consider evaluating the company's recent financial performance, growth potential, and overall market conditions to ensure it aligns with your investment goals. Additionally, assess whether the stock's current valuation justifies the potential for future returns and if it fits your risk tolerance.

Can Bafna Pharmaceuticals Ltd stock price continue to rise after reaching its 52-week high?

Bafna Pharmaceuticals Ltd stock price can continue to rise after reaching its 52-week high if it maintains strong fiscal performance and favorable market conditions. However, future growth depends on numerous factors such as company earnings, industry trends, and broader economic conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions